Sign In
Get Clay Free →

Suggestions

    Brad Prosek

    Brad Prosek is a prominent executive in the life sciences sector, currently serving as an Operating Partner and Executive in Residence at EcoR1 Capital, LLC since November 2022. He also holds a board member position at Epikast, which he began in April 2024. Additionally, Prosek is the President of All Terrain bioPartners LLC, a role he has maintained since April 2015, focusing on business development and corporate strategy for life science companies.2

    His extensive career includes significant roles such as Chief Business Officer and Senior Vice President of Corporate Development at Constellation Pharmaceuticals from September 2017 to July 2021. During his tenure, he was instrumental in leading initiatives related to infection prevention and corporate development at Cubist Pharmaceuticals from March 2005 to April 2015. Prosek's early career includes positions at Biogen Idec and Covance Market Access Services.23

    Prosek holds an MBA in Finance and Operations from Columbia Business School and a BSFS in International Relations and Biochemistry from Georgetown University.2 His expertise spans over 25 years in the biotechnology industry, where he has developed a reputation for strategic planning and market understanding.12

    Highlights

    Nov 5 · theorg.com
    Brad Prosek - Operating Partner at EcoR1 Capital - The Org
    Brad Prosek on Getting to Know an Unconventional Acquirer

    Related Questions

    What are Brad Prosek's main responsibilities at EcoR1 Capital?
    How did Brad Prosek contribute to the success of Constellation Pharmaceuticals?
    What is the focus of All Terrain bioPartners LLC under Brad Prosek's leadership?
    Can you provide more details about Brad Prosek's role at Epikast?
    What was Brad Prosek's impact at Cubist Pharmaceuticals?
    Brad Prosek
    Add to my network

    Location

    Greater Boston